Aesculap
Payments companies reported to CMS as associated with Aesculap. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Aesculap, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Aesculap
These are the largest totals companies reported as associated with Aesculap. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kevin Foley | Memphis, TN | Neurological Surgery | $242,000.00 |
| Roger Jackson | North Kansas City, MO | Orthopaedic Surgery of The Spine | $152,329.24 |
| Jeffrey Beecher | Wilmington, NC | Neurological Surgery | $56,070.08 |
| David Langer | New York, NY | Neurological Surgery | $22,261.47 |
| Michael Lawton | Phoenix, AZ | Neurological Surgery | $21,000.00 |
| Chirag Patil | West Hollywood, CA | Neurological Surgery | $19,692.07 |
| Shawn Vuong | Sioux Falls, SD | Neurological Surgery | $19,386.68 |
| Bryan Figueroa | Grand Rapids, MI | Neurological Surgery | $17,770.06 |
| Fady Charbel | Chicago, IL | Neurological Surgery | $17,084.93 |
| Gerald Grant | Stanford, CA | Neurological Surgery | $13,649.86 |
Prescribed Aesculap?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.